Glycine derivative process for preparation thereof, and pharmaceutical composition containing it
申请人:TANABE SEIYAKU CO., LTD.
公开号:EP0375557A1
公开(公告)日:1990-06-27
Novel glycine derivative having the formula (I):
wherein R¹ is a substituted or unsubstituted phenyl group; either R² or R³ is a lower alkyl group and the other is hydrogen atom, R⁴ is a protected or nonprotected carboxyl group, Q is a lower alkylene group and m is O or 1
or a pharmaceutically acceptable salt thereof are disclosed. Said derivative (I) and a pharmaceutically acceptable salt thereof have a potent platelet aggregation-inhibiting acitivity.
揭示了具有以下式(I)的新型甘氨酸衍生物:其中R¹是取代或未取代的苯基;R²或R³是较低的烷基,另一个是氢原子;R⁴是受保护或非受保护的羧基;Q是较低的烷基,m为O或1,或其药用可接受盐。所述衍生物(I)及其药用可接受盐具有强大的抑制血小板聚集活性。